Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
46 Cards in this Set
- Front
- Back
DM Criteria?
|
Casual plasma glucose>/= 200 mg/dl and sympt of DM
polyuria, polydipsia, ketoacidosis, or unexplained wt loss OR fasting plasma glucose >/= 126mg/dl OR results of a 2 hr 75 g OGTT>/= 200 (last 2 should be confirmed with a repeast test on a different day) |
|
Fasting Plasma Glucose or Preprandial Glucose Goal?
Normal? |
70-130
Normal <100 |
|
Postprandial 2 hrs goal?
Normal? |
<180
Normal <140 |
|
Bedtime Glucose goal?
Normal? |
90-150
Normal <120 |
|
A1C goal?
normal? |
7%
Normal 6% |
|
How many times a uear should A1C be done?
|
2-4 times a yr
|
|
Most pts with type 1 DM should monitor BS?
|
3 times a day
|
|
Best time to measure?
|
2-3 times postprandially
fasting and preprandial for 2-4 days consecutively |
|
When should 1 hr postprandial be monitored?
|
alpha glucosidase inhib
during preg |
|
Mild to moderate hypoglycemia?
|
51-70 and <90 mg/dl at HS
Mild to moderate hypoglycemia |
|
Mild to moderate hypoglycemia
tx? |
15-20 g carb
(1/2 c juice or reg soft drink 3-4 glucose tabs 8-10 hard candies) |
|
</=50 tx?
|
20-30 g carb and recheck BG in 15 min
follow with additional carb or snack if next meal is more than 1 hr away |
|
Sever hypo?
|
altered consciousness, unable to take carb orally or requiring the assistance of another person, tx with glucagon and or IV glucose
|
|
Physical act for DM?
|
min of 150-175 mi of moderate intensity/wk
target of 60-90 min 6-7 days per wk resist. training qod to increase lean body mass |
|
How ofter should serum creat be measured?
|
at min annually to est. GFR
|
|
If GFR<60?
|
eval for complications of kid dx
anemia hyperparathyroidism vit d def |
|
Screen for micro/macro albuminuria by checking urine?
|
a/c ratio
type 1 within 5 yrs then yrly type 2 at diag annually til 70 |
|
How do you screen for micro/macro albuminuria by checking urine?
|
spot or timed urine
|
|
With which result do you A/C anually?
|
under 30 timed or spot
|
|
What can cause a false + A/C test?
|
preg
UTI excessive execr menses severe hypoglycemia |
|
If A/C 30-300, how do you confirm presence of micro alb?
|
at least 2-3 positive collections done within 3-6 months and r/o other reasons
Consider a consult w/ nephro |
|
Once A/C of 30-300 confirmed, what do you do ?
|
BP goal 130/80
Refer to a DE ACE I (check K and Cr 1-2 wks after ACE) Repeat A/C at least q 6 mo, consider more freq when change in meds are made |
|
If ratio >300 OR protienuria by + dipstick?
|
gaol of 125/75
consult with nephro consider reducing protien in the diet |
|
After how long do you check lipids
|
6 wks
|
|
When do you
start MNT Physical activity & consider Metformin? |
KIAS
K- No ketones in the urine I-no acute or concurrent illness A-A1C</= 7.5% S-mild or no sympts |
|
With KIAS, What do you do?
K- No ketones in the urine I-no acute or concurrent illness A-A1C</= 7.5% S-mild or no sympts |
start MNT
Physical activity & consider Metformin? |
|
If target not met within ___, then?
|
If target not met with 6 WEEKS, then START ORAL ANTIHYPERGLYCEMIC
|
|
When do you automatically start oral antihyperglycemics?
|
FPG > 150
Random >250 AND/OR A1C>7.5% Does not meet the criteria for mild or severe |
|
When do you start Insulin immediately?
|
HWH SKID
h-severe Hyperglycemia w-sever wt loss h-HHNK s-severe/sig sympts k-ketones 2+ i-concurrent illness/ surgery d-DKA |
|
How do you approach antihyerglycemic meds?
|
titrate dose over 1-6 months
reinforce MNT and Physical activity |
|
When do you add a 2 nd antihyperglycemic
|
titrate dose over 1-6 months
reinforce MNT and Physical activity IF A1c>7 OR fasting plasma glucose >130 mg/dl OR 2 hr postprandial glucose>180 mg/dl add 2nd oral antihyperglycemia OR GLP 1 agonist OR insulin |
|
Metformim is best used in which pts?
|
•*Overweight/obese*
•Renal/liver function normal |
|
Metformin's Contraindicated in which pts?
|
•Creatinine > 1.4 (women)
•Creatinine > 1.5 (men) •IV contrast•Dehydration •Alcohol excess •> 80 years age (unless creatinine clearance allows) |
|
Thiazolidinediones (TZDs) are best used in which pts?
|
•*Overweight/obese, signs of insulin resistance
•Liver function normal: need to follow LFT monitoring schedule •Can be used in renal impairment but may increase fluid retention •Consider risk for bone loss and fracture Note: Full effect of initiation or titration of therapy may take 2-4 months to be seen |
|
Clases of the Insulin Secretagogue?
|
sulfonylurea or short-acting secretagogue)•sulfonylurea or short-acting secretagogue) are best used for which pts?
|
|
Repaglinide or nateglinide are useful for patients with?
|
postprandial hyperglycemia or with hypoglycemia on sulfonylurea
|
|
Sulfonylureas are contraindicated in pts with ?
|
in severe liver or renal disease
|
|
α-Glucosidase Inhibitor are best used with which pts?
|
•Milder presentation
•Use if postprandial hyperglycemia is the predominant hyperglycemic pattern •No GI symptoms |
|
Alpha α-Glucosidase Inhibitor's Contraindicated with which pts?
|
•Chronic intestinal disorders
•Acarbose in cirrhosis •Acarbose and miglitol in renal impairment(creatinine > 2.0) |
|
When do you use (dipeptidyl peptidase IV Inhibitors) DPP-4 Inhibitors?
|
•Use if postprandial hyperglycemia is the predominant hyperglycemic pattern
•Weight neutral •Reduce in renal dx |
|
When are Dipeptidyl Peptidase IV Inhibitors Contraindicated?
|
Not known at this time
|
|
Bile Acid Sequestrant (colesevelam) used as?
|
•Adjunct to other treatment modalities
•Modest effect on A1C. Also lowers LDL-C Note: Reduces gastric absorption of some drugs. If known interaction or unknown interaction with narrow therapeutic index drug, administer 1 hour prior or 4 hours after colesevelam |
|
Bile Acid Sequestrant(colesevelam) Contraindicate?
|
•Bowel obstruction
•Serum triglyceride > 500mg/dl •Hx of hypertriglyceridemia-induced pancreatitis |
|
How do you titrate antihyper meds?
|
Titrate Dose over 1 –6 months &Reinforce MNT and Physical Activity
|
|
2 Hour Postprandial Glucose > 180 mg/dl what do you do?
|
•Administered subcutaneously twice daily
•Use if postprandial hyperglycemia predominates •To avoid hypoglycemia if using with a sulfonylurea, consider initially decreasing sulfonylurea dose. Use may be associated with weight loss |
|
GLP-1 agonist Contraindicated?
|
•Gastroparesis requiring treatment with metoclopramide
•History of pancreatitis |